Osteopenia: Zoledronic Acid Has Greater Impact Than Switching From Tenofovir Disoproxil Fumarate Regimens
For HIV-positive men with osteopenia, bisphosphonate therapy with zoledronic acid is more effective at increasing bone mineral density than switching from tenofovir disoproxil fumarate (TDF, Viread).
A 12-year analysis of the large NA-ACCORD cohort showed that more than half of those who could use a statin to treat their cardiovascular diseasehad not received a prescription for it.
The 2017 Synchronicity Conference, a national conference that focuses on HIV and hepatitis C, also addressed LGBT health for the first time this year.
What if an electronic medical record-based algorithm could make it easier and quicker to place individuals living with hepatitis C in the care cascade? That's exactly what one study is looking into, as it aims to help identify and get individuals wit...
One study set out to evaluate the role that the microbiome plays in HIV-associated neurocognitive disorders. Terri Wilder, M.S.W., spoke with study author Josue Perez-Santiago, Ph.D., at CROI 2017.
There is a significant "statin treatment gap" for people living with HIV, with only 47% of people eligible for statins receiving them in 2013, according to a recent study.
Incidence of all cancers combined fell in the years after HIV-positive people stopped smoking, according to results of a nine-year 35,424-person analysis.
Higher total bilirubin predicted incident cardiovascular disease in an analysis of 98,405 U.S. veterans with or without HIV infection.
The effect of even well-controlled HIV on the brain is not receiving enough attention. Now that people living with HIV no longer need to focus only on survival, quality-of-life issues must be addressed.
One subcutaneous dose of canakinumab, a monoclonal antibody to IL-1β, significantly reduced arterial inflammation in 10 individuals with well-controlled HIV.